logo logo

JYSELECA: once-daily tablet, same simple dosing regimen for induction and maintenance1

 

simple dosing regimen simple dosing regimen simple dosing regimen
simple dosing regimen
simple dosing regimen
simple dosing regimen

JYSELECA: A simple choice

Reference: 1. Feagan BG, Danese S, Loftus EV Jr, et al. Lancet 2021;397:2372–2384. 

INDICATIONS: JYSELECA is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV. JYSELECA is a registered or pending trademark of Gilead Sciences, Inc., or one of its related companies.

UK-IBD-FIL-202203-00033
Date of preparation March 2022

Find us here too

GALAPAGOS and the GALAPAGOS logo are registered or pending trademarks of Galapagos NV. JYSELECA is a registered or pending trademark of Gilead Sciences, Inc., or one of its related companies.

UK-IBD-FIL-202203-00033
Date of preparation March 2022

Privacy Policy
Terms of Use
Site Map

© 2022 Galapagos NV. All rights reserved.